---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-104254"
form_type: "8-K"
ticker: "RGEN"
cik: "0000730272"
company_name: "REPLIGEN CORP"
filed_at: "2023-04-18T23:59:59+00:00"
generated_at: "2026-06-17T01:00:17.492223+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "medium"
source: SEC EDGAR
---

# Repligen completes acquisition of FlexBiosys Inc. on April 17, 2023

## Summary
- Completed acquisition of all outstanding equity of FlexBiosys Inc. on April 17, 2023.
- Equity Purchase Agreement signed April 12, 2023, with sellers TSAP Holdings, Gayle Tarry, and Stanley Tarry.
- No deal value or financial terms disclosed in this filing.

## SEC filing metadata
- accession: 0001193125-23-104254
- form_type: 8-K
- ticker: RGEN
- cik: 0000730272
- company_name: REPLIGEN CORP
- filed_at: 2023-04-18T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: medium
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/730272/000119312523104254/0001193125-23-104254-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/730272/000119312523104254/d464614d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-104254
- JSON: https://secwatch.observer/filing/0001193125-23-104254.json
- Plain text: https://secwatch.observer/filing/0001193125-23-104254.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.